PARASTOP – Paracetamol with Strong Opioids. A randomized, double-blind, parallel-group non-inferiority phase III withdrawal trial of paracetamol versus placebo in conjunction with opioids for moderate to severe cancer-related pain
RecruitingCTIS2024-515012-53-00
Oslo University Hospital HFMetastatic cancer disease
Start: 2021-10-20Target: 179Updated: 2025-05-19